Minimally Invasive Techniques for Treating Large Proximal Ureteral Stones
NCT ID: NCT06199518
Last Updated: 2024-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
105 participants
INTERVENTIONAL
2021-04-01
2023-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Primary Ureteroscopy for Acute Obstructive Nephropathy Due to Ureteral Stones: A Prospective Non-randomized Feasibility and Safety Trial
NCT07177313
Flexible urétéroscopy Versus Extracorporeal Shockwave Lithotripsy in Renal Calculi
NCT01604304
Management of Medium Sized Renal Stones
NCT06720311
Flexible Ureteroscopy Versus Extracorporeal Shock Wave Lithotripsy
NCT07193940
Flexible Ureteroscopy Versus Mini-Percutaneous Nephrolithotomy for Treatment of Renal Stones
NCT03932370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A total of 105 participants were enrolled in the trial between April 2021 and June 2023 to accomplish this. Inclusion criteria for this study included patients who had a single proximal Ureteral stone (between the pelvi ureteric junction and the upper border of the sacroiliac joint) measuring 15-20 mm in diameter.
Patients were randomly allocated to receive either TPLU, RURS, or Minin-perc Antegrade URS, with a 1:1:1 allocation ratio. After providing informed permission, the patients were randomly assigned to one of three groups: Group I (35 patients treated with TPLU), Group II (35 patients treated with RURS), and Group III (35 patients not treated with either TPLU or RURS) (Included 35 patients who were treated by Mini-perc Antegrade URS)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GROUP(A):transperitoneal laparoscopic ureterolithotomy (T-LUL)
extraction of proximal ureteral stones by laparoscopic surgery via transperitoneal approach
transperitoneal laparoscopic ureterolithotomy (T-LUL)/ retrograde flexible ureteroscopy (R-URS) /Antegrade mini-percutaneous flexible ureteroscopy (A-URS)
extraction or fragmentation of large proximal ureteral stones via different minimally invasive procedures
GROUP (B):retrograde flexible ureteroscopy (R-URS)
laser lithotripsy of proximal ureteral stones via flexible ureteroscopy retrograde
transperitoneal laparoscopic ureterolithotomy (T-LUL)/ retrograde flexible ureteroscopy (R-URS) /Antegrade mini-percutaneous flexible ureteroscopy (A-URS)
extraction or fragmentation of large proximal ureteral stones via different minimally invasive procedures
GROUP (C):Antegrade mini-percutaneous flexible ureteroscopy (A-URS)
laser lithotripsy of proximal ureteral stones via percutanous antegrade flexible ureteroscopy
transperitoneal laparoscopic ureterolithotomy (T-LUL)/ retrograde flexible ureteroscopy (R-URS) /Antegrade mini-percutaneous flexible ureteroscopy (A-URS)
extraction or fragmentation of large proximal ureteral stones via different minimally invasive procedures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
transperitoneal laparoscopic ureterolithotomy (T-LUL)/ retrograde flexible ureteroscopy (R-URS) /Antegrade mini-percutaneous flexible ureteroscopy (A-URS)
extraction or fragmentation of large proximal ureteral stones via different minimally invasive procedures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* large proximal ureteral stones(1.5-2 cm)
Exclusion Criteria
* multiple stones
* bleeding tendency
* active UTI
* distal stricture
26 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Zoeir
faculty of medicine, Tanta, ElGeish street, Egypt
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urolgy Departement, Faculty of Medicine, Tanta University
Tanta, Outside U.S./Canada, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
34619/4/21
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.